CYCLOBENZAPRINE HYDROCHLORIDE TABLETS

The Defense Logistics Agency awarded a delivery order under the base contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, a small disadvantaged and women-owned small business with CAGE code 1UNB0, for the procurement of 4 bottles of Cyclobenzaprine Hydrochloride Tablets (NSN 6505010628010) at a total contract price of $188.04. The order, issued on July 14, 2026, with a required delivery date of July 29, 2026, is delivered FOB destination to Fort Stewart, Georgia, with the contractor bearing all shipping costs and risks until receipt by the Government. Packaging and marking requirements mandate that all shipments use traceable shipping methods, excluding parcel post, and must clearly display the base contract number SPE2DX-25-D-9900 and delivery order number SPE2DP-26-F-7688 in block letters on all containers and documents. Inspection and final acceptance occur at the destination, with the Government responsible for verifying conformance to contract specifications, but no specific external standards like USP or MIL-STD are cited. Payment will be processed by the Defense Finance and Accounting Service through a DoD voucher system using the remit-to address P.O. Box 182317, Columbus, OH 43218-2317, with the accounting line BX: 97X4930 5CBX 001 2620 S33189. The contracting officer, Lisa Quinn, and administrative support contact Shairy M. Cartagena are the primary points of contact, and no option quantities, quantity variances, or substitutions beyond medical substitution are permitted. The order is fixed-price, non-modifiable, and lacks explicit FAR clauses, evaluation factors, or attachment requirements, functioning as a straightforward, low-value fulfillment under a pre-established indefinite-delivery framework.